Zydus inks licensing agreement with Daewoong Pharmaceutical for leuprolide injectable in the US
The exclusive agreement also includes development, regulatory, and commercialization milestone payments based on the successful outcome
The exclusive agreement also includes development, regulatory, and commercialization milestone payments based on the successful outcome
The agreement includes an upfront payment of US$15 million, regulatory and commercial milestones, and royalties
Syngene gains access to ERS Genomics' foundational CRISPR/Cas9 patent portfolio, ushering in a new era of technical innovation in India for its global partners
Juergen Eckhardt joined Bayer in 2016 to help start Leaps by Bayer
The TBDA is a collaboration established among biopharmaceutical companies, research organizations and universities to accelerate the discovery and development of novel therapeutic candidates against TB.
Yoshindo gets exclusive commercialization rights in Japan for bUstekinumab and bDenosumab developed and manufactured by Biocon Biologics
The Department of Health and Family Welfare updated the preparedness for transition to licensing of Class-A and Class-B medical devices with effect from 1st October, 2022 under Medical Devices Rules 2017
Lupin’s subsidiary in Philippines, Multicare Pharmaceuticals, will file for marketing approval and be responsible for distribution and commercialization of the biosimilars once approved.
Genentech will be granted an exclusive license to develop and commercialize the degrader worldwide, and will be fully responsible for the development and commercialization costs.
Subscribe To Our Newsletter & Stay Updated